---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-023580"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-08-13T23:59:59+00:00"
generated_at: "2026-05-17T13:55:11.855333+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma appoints Jeannine Zimmerman as CFO effective Aug 13, 2025

## Summary
- Jeannine Zimmerman, age 48, appointed CFO effective August 13, 2025.
- She holds a B.S. in accounting from St. Joseph's College; experience includes SEC filings, audit, and SOX 404 testing.
- Prior to appointment, CEO James Nathanielsz had served as both CEO and CFO.

## SEC filing metadata
- accession: 0001641172-25-023580
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-08-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000164117225023580/0001641172-25-023580-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000164117225023580/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-023580
- JSON: https://secwatch.observer/filing/0001641172-25-023580.json
- Plain text: https://secwatch.observer/filing/0001641172-25-023580.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.